Fernando Najera

Business Development & Licensing Analyst at Novartis - Basel, Basel-City, CH

Fernando Najera's Colleagues at Novartis
Idil Ismail

Business Franchise Head Oncology

Contact Idil Ismail

Bernard Arcangel

Head of Commercial Excellence

Contact Bernard Arcangel

Nassima Ziane

Quality Project Leader (Technical Research &Development)

Contact Nassima Ziane

Felipe Macedo

Immunology District Manager

Contact Felipe Macedo

Isabelle Gilloteau

Worldwide Access Product Lead Lung Cancer

Contact Isabelle Gilloteau

View All Fernando Najera's Colleagues
Fernando Najera's Contact Details
HQ
+41 61 324 11 11
Location
Mexico City,Federal District,Mexico
Company
Novartis
Fernando Najera's Company Details
Novartis logo, Novartis contact details

Novartis

Basel, Basel-City, CH • 79173 Employees
Major Drugs

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Pharmaceutical Drugs Innovative Medicine Healthcare Solution Biotechnology Medical Research Clinical Trials Pharmaceutical Manufacturing Drug Development And Manufacturing Health Technology
Details about Novartis
Frequently Asked Questions about Fernando Najera
Fernando Najera currently works for Novartis.
Fernando Najera's role at Novartis is Business Development & Licensing Analyst.
Fernando Najera's email address is ***@novartis.com. To view Fernando Najera's full email address, please signup to ConnectPlex.
Fernando Najera works in the Major Drugs industry.
Fernando Najera's colleagues at Novartis are Idil Ismail, Bernard Arcangel, Nassima Ziane, Iskender Erdem, Felipe Macedo, Isabelle Gilloteau, Eucheria Johnson and others.
Fernando Najera's phone number is +41 61 324 11 11
See more information about Fernando Najera